GlassScriptPhysician profile
Kirk R Jeffreys
NPI 1902998040
$9,149.92
in general payments reported to CMS, 2019-2025
24 companies · $1,682 in 2025
The $1,682 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $963 · 2021: $1,263 · 2022: $1,492 · 2023: $1,353 · 2024: $1,312 · 2025: $1,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,311 · Honoraria: $25.59 · Education: $10.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,311.14 |
| Honoraria | $25.59 |
| Education | $10.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,732.30 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Mallinckrodt Hospital Products INC. | $1,257.72 | 2020-2025 | Acthar |
| Abbvie INC. | $893.45 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $551.88 | 2019-2023 | |
| Allergan, INC. | $519.55 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $426.26 | 2019-2024 | Cequa |
| Oyster Point Pharma, INC. | $380.11 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $258.05 | 2022-2024 | Miebo, Vyzulta, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $247.90 | 2019-2023 | Catalys System, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $182.73 | 2019-2021 | |
| Rxsight INC | $122.95 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Tarsus Pharmaceuticals, INC. | $122.75 | 2024-2025 | Xdemvy |
| Omeros Corporation | $85.49 | 2019-2021 | |
| Biotissue Holdings INC. | $82.56 | 2022-2024 | |
| New World Medical,INC. | $70.36 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $49.57 | 2020-2022 | |
| Shire North American Group INC | $33.31 | 2019 | |
| Beaver-Visitec International, INC. | $22.03 | 2023 | |
| Aerie Pharmaceuticals, INC. | $21.00 | 2021 | |
| Thea Pharma INC. | $20.83 | 2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $19.56 | 2019 | |
| Ocular Therapeutix, INC. | $18.34 | 2022 | |
| Sight Sciences, INC. | $16.60 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Amgen INC. | $14.62 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Jeffreys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.